Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;125(12):e30406.
doi: 10.1002/jcb.30406. Epub 2023 Apr 23.

Structure and function of the TPR-domain immunophilins FKBP51 and FKBP52 in normal physiology and disease

Affiliations
Review

Structure and function of the TPR-domain immunophilins FKBP51 and FKBP52 in normal physiology and disease

Olga B Soto et al. J Cell Biochem. 2024 Dec.

Abstract

Coordinated cochaperone interactions with Hsp90 and associated client proteins are crucial for a multitude of signaling pathways in normal physiology, as well as in disease settings. Research on the molecular mechanisms regulated by the Hsp90 multiprotein complexes has demonstrated increasingly diverse roles for cochaperones throughout Hsp90-regulated signaling pathways. Thus, the Hsp90-associated cochaperones have emerged as attractive therapeutic targets in a wide variety of disease settings. The tetratricopeptide repeat (TPR)-domain immunophilins FKBP51 and FKBP52 are of special interest among the Hsp90-associated cochaperones given their Hsp90 client protein specificity, ubiquitous expression across tissues, and their increasingly important roles in neuronal signaling, intracellular calcium release, peptide bond isomerization, viral replication, steroid hormone receptor function, and cell proliferation to name a few. This review summarizes the current knowledge of the structure and molecular functions of TPR-domain immunophilins FKBP51 and FKBP52, recent findings implicating these immunophilins in disease, and the therapeutic potential of targeting FKBP51 and FKBP52 for the treatment of disease.

Keywords: FKBP51; FKBP52; immunophilin.

PubMed Disclaimer

References

    1. Acar N and Ustunel I (2015). “Expression of 52-kDa FK506-binding protein (FKBP52) in human placenta complicated by preeclampsia and intrauterine growth restriction.” Anal Quant Cytopathol Histpathol 37(2): 87–95. - PubMed
    1. Bailus BJ, Scheeler SM, Simons J, Sanchez MA, Tshilenge KT, Creus-Muncunill J, Naphade S, Lopez-Ramirez A, Zhang N, Lakshika Madushani K, Moroz S, Loureiro A, Schreiber KH, Hausch F, Kennedy BK, Ehrlich ME and Ellerby LM (2021). “Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.” Autophagy 17(12): 4119–4140. - PMC - PubMed
    1. Baker JD, Ozsan I, Rodriguez Ospina S, Gulick D and Blair LJ (2018). “Hsp90 Heterocomplexes Regulate Steroid Hormone Receptors: From Stress Response to Psychiatric Disease.” Int J Mol Sci 20(1). - PMC - PubMed
    1. Bauder M, Meyners C, Purder PL, Merz S, Sugiarto WO, Voll AM, Heymann T and Hausch F (2021). “Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors.” J Med Chem 64(6): 3320–3349. - PubMed
    1. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF and Ressler KJ (2008). “Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.” JAMA 299(11): 1291–1305. - PMC - PubMed

Publication types

Substances

LinkOut - more resources